| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NBIX over the last quarter tilts toward selling: insiders offloaded a net 6,541 shares worth roughly $1.1M.
Classified under Pharmaceuticals (Health Care sector), NBIX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 517.8K | $80.89M | - | |
| CEO | 154.7K | $24.17M | - | |
| Other | 67.3K | $10.51M | - | |
| Other | 56.8K | $8.87M | - | |
| CFO | 42.8K | $6.73M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | Lippoldt Darin60 | Chief Legal Officer | Sell | 1,250 | $109.97 | $137,464.00 | -4.0% | -6.2% | +26.0% | |
| Jan 31, 2023 | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 2,707 | $110.08 | $297,997.12 | -0.6% | -6.2% | +26.0% | |
| Jan 31, 2023 | Gano Kyle54 | Chief Business Development Off | Sell | 1,541 | $109.98 | $169,486.42 | -1.3% | -6.2% | +26.0% | |
| Jan 31, 2023 | Cooke Julie59 | Chief Human Resources Officer | Sell | 916 | $108.48 | $99,367.68 | -5.4% | -6.2% | +26.0% | |
| Jan 31, 2023 | Boyer David W.51 | Chief Corp. Affairs Officer | Sell | 1,104 | $109.92 | $121,348.59 | -22.0% | -6.2% | +26.0% | |
| Jan 31, 2023 | Benevich Eric62 | Chief Commercial Officer | Sell | 1,207 | $109.95 | $132,710.25 | -6.7% | -6.2% | +26.0% | |
| Jan 31, 2023 | Abernethy Matt57 | Chief Financial Officer | Sell | 1,283 | $109.98 | $141,107.80 | -5.7% | -6.2% | +26.0% | |
| Jan 6, 2023 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 400 | $125.00 | $50,000.00 | -2.5% | -14.8% | +7.7% | |
| Jan 3, 2023 | Sherwin Stephen A | Director | Sale+OE | 30,000 | $118.86 | $3,565,728.00 | -54.5% | -16.0% | +10.5% | |
| Jan 3, 2023 | Pops Richard F57 | Director | Sale+OE | 15,000 | $119.20 | $1,788,045.00 | -33.7% | -16.0% | +10.5% |